v3.26.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Weighted Average Grant Fair Value of Stock Options Using Black-Scholes Option-Pricing Model

The following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted during the years ended December 31, 2025 and 2024:

 

   Year Ended December 31, 
   2025   2024 
Risk-free interest rate   3.9%   4.4%
Expected term (in years)   5.3    5.7 
Expected volatility   98.1%   104.9%
Expected dividend yield        
Schedule of Stock Option Activity

The following table summarizes option activity with service conditions under the 2021 Plan and the 2017 Plan:

 

   Options  

Weighted

Average

Exercise Price

  

Weighted

Average

Contract Term

(years)

  

Aggregate

Intrinsic

Value

 
Outstanding at January 1, 2025   3,961,525   $27.27    6.4   $                 16 
Granted   931,336    1.50           
Exercised   (38,430)   2.80           
Forfeited/Expired   (912,671)   15.63           
Outstanding at December 31, 2025*   3,941,760   $24.12    7.0   $ 
Vested and expected to vest at December 31, 2025   3,941,760   $24.12    7.0   $ 
Exercisable at December 31, 2025   2,568,592   $35.51    5.7   $ 

 

* Options outstanding at December 31, 2025 under the 2021 Plan and 2017 Plan were 3,100,493 and 886,267, respectively. Options outstanding at December 31, 2025 under the 2021 Plan include 45,000 awards with performance conditions (see below).
Schedule of Warrants Purchase Agreement

 

Tranche  Shares   Exercise Price   Vesting Conditions
1   600,000   $3.00   50,000 warrants vest monthly from Feb 1, 2025, with the first 50,000 warrants vesting immediately upon execution.
2   200,000   $5.00   Vest upon the closing of a specified transaction.
3   200,000   $6.00   Vest upon the closing of the same transaction.
4   500,000   $12.00   Vest ratably over 12 months from May 19, 2025.
    1,500,000         
Schedule of Activity Related to RSU Stock-Based Payment Awards

The following table summarizes activity related to RSU stock-based payment awards under the 2021 Plan:

 

  

Number of

Shares

  

Weighted

Average

Grant Date Fair Value

 
Outstanding at January 1, 2025   659,439   $9.29 
Granted   781,813   $1.43 
Vested   (628,386)  $5.83 
Forfeited   (169,007)  $4.13 
Outstanding at December 31, 2025   643,859   $4.48 
Schedule of Stock-based Compensation Expense

The Company recorded stock-based compensation expense in the following expense categories of its consolidated statement of operations and comprehensive loss:

 

Schedule of Stock-based Compensation Expense

       
   Year Ended December 31, 
   2025   2024 
Cost of revenues  $287   $450 
Research and development   767    1,287 
Selling, general and administrative   9,588    9,832 
Stock-based compensation expense  $10,642   $11,569 
           
Stock-based compensation due to stock options with service conditions  $

5,081

   $

8,336

 
Stock-based compensation due to RSU’s, including director fees paid with RSU’s of $264   3,062    

3,022

 
Stock-based compensation due to MCU’s   

30

    

211

 

Stock-based compensation due to October 2025 Consultant warrants market condition award

   

2,469

    

 
Stock-based compensation expense  $10,642   $11,569